NITROFURANTOIN
It is a primarily bacteriostatic compound, but may be cidal at higher concentrations and in acid urine its activity is enhanced at lower pH. It inhibits many gram negative bacteria, but due to evelopment of resistance, activity is now restricted largely to E.coli. It antagonizes the action of nalidixic acid.Urinary tract infection. Cystitis, pyelitis & pyelonephritis; post-operative infections of urinary tract.
50-100 mg 6 hrly with meals. Children : 6 mg/kg bodywt. daily in 4 divided doses.
Impaired renal function. Pregnancy, neonates, severe oliguria, anuria.
Urine turns dark brown on exposure to air. Liver damage & a pulmonary reaction. Concomitant use of Probenecid & Nalidixic acid. Acidify urine. Paediatrics: Contraindicated in under 1 year. Pregnancy: Safety not established. Lactation: Use with caution. May cause anaemia in G6PD deficient infants. Elderly: No special problem.
G.I. intolerance-nausea, diarrhoea. Chills fever & leucopenia. Peripheral neuritis & neurological effects. Haemolytic anaemia.
Antagonise Nalidixic acid. Absorbtion reduced by Magnesium trisilicate. Probenecid reduces excretion.Urinary excretion of Pyridoxin increased.
Brand Name | Manufactured by |
---|---|
FURADANTIN WITH LIQUORICE | GLAXO-SMITHKLINE |
NEPHROGESIC | JOHNSON AND JOHNSON |